retatrutide clinical trial south korea Preventing obesity-related cancer with the revolution in obesity management: the challenges of undertaking a and potential solutions Eli Lilly's retatrutide sets new

Clinical trial starting doses The landmark phase 2 trial published in the New England Journal of Medicine randomized 338 participants across multiple dose groups

The effect of exenatide once weekly on carotid atherosclerosis in individuals with type 2 diabetes: an 18-month randomized placebo-controlled study

Does retatrutide work only by reducing appetite

Markets Europe Markets China Markets Asia Markets World Markets Currencies Prediction Markets Cryptocurrency Futures & Commodities Bonds Funds & ETFs Business Economy Finance Health & Science Media Real Estate Energy Climate Transportation Investigations Industrials Retail Wealth Sports Life Small Business Investing Personal Finance Fintech Financial Advisors Options Action ETF Street Buffett Archive Earnings Trader Talk Tech Cybersecurity AI Enterprise Internet Media Mobile Social Media CNBC Disruptor 50 Tech Guide Politics White House Policy Defense Congress Expanding Opportunity Europe Politics China Politics Asia Politics World Politics Video Latest Video Full Episodes Livestream Top Video Live Audio Europe TV Asia TV CNBC Podcasts CEO Interviews Digital Originals Watchlist Investing Club Trust Portfolio Analysis Trade Alerts Meeting Videos Homestretch Jim's Columns Education Subscribe PRO Pro News Josh Brown Mike Santoli Calls of the Day My Portfolio Livestream Full Episodes Stock Screener Market Forecast Options Investing Chart Investing Subscribe Livestream Make It select USA INTL Livestream Livestream Watchlist SIGN IN Create free account Markets Business Investing Tech Politics Video Watchlist Investing Club PRO Livestream watch now Share Money Movers CNBC's Angelica Peebles reports the latest news surrounding GLP-1 drugs

Eberl G, Colonna M, Di Santo JP, McKenzie AN